The present invention relates to novel cephalosporin antibiotics, prodrugs thereof and pharmacologically acceptable salts of either, which are active against a wide spectrum of bacteria that are resistant to present clinical beta-lactam antibiotics.
本发明涉及新型
头孢菌素抗生素,其前药及其药理学上可接受的盐,对目前临床β-内酰胺类抗生素产生耐药性的广谱细菌具有活性。